Supplementary protection certificates: where are we and where are we going? (an update)
Plausibility of second medical use patents: pregabalin in the Supreme Court
The grant of an SPC for a new therapeutic application
Biosimilars – pricing and reimbursement and the competitive landscape
by multiple authors
Infringement of second medical use patents in the UK: pregabalin in the Supreme Court
Prescription to patenting: cannabis-derived medicinal products
The what, why and how of the UK Supreme Court Warner-Lambert decision
by multiple authors
Transceiver - Autumn 2018
by multiple authors
Further analysis: Unwired Planet v Huawei